Home UVB Machines Showed Clear Benefit in Patients With Psoriasis
Nearly two-thirds of patients with psoriasis who received a home-based narrow-band ultraviolet B (NBUVB) device did not use in-office NBUVB treatments or systemic therapy for a full year after receiving the device. According to research findings published in , among 2,207 patients who received in-home NBUVB devices, 1,431 (64.8%) did not use in-office NBUVB or systemic therapy for a full year afterward.